Active Filters

  • (-) PSI Authors = Lindenblatt, Dennis
Search Results 1 - 2 of 2
  • RSS Feed
Select Page
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma
Lindenblatt, D., Terraneo, N., Pellegrini, G., Cohrs, S., Spycher, P. R., Vukovic, D., … Grünberg, J. (2018). Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma. BMC Cancer, 18, 922 (14 pp.). https://doi.org/10.1186/s12885-018-4836-1
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model
Grünberg, J., Lindenblatt, D., Dorrer, H., Cohrs, S., Zhernosekov, K., Köster, U., … Schibli, R. (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European Journal of Nuclear Medicine and Molecular Imaging, 41(10), 1907-1915. https://doi.org/10.1007/s00259-014-2798-3